Michele M. Cox, Ph.D.
Postdoctoral Research Associate
- Ph.D. Biomedical Sciences, June 2006, Drexel University, Philadelphia, PA
- M.A. Life Sciences, August 1998, SUNY at Stony Brook, Stony Brook, NY
- B.A. American History, Minor in Human Reproduction, May 1997, SUNY at Stony Brook, Stony Brook, NY
One of the focus of Dr. Rivkees’ research is the understanding of how altered proliferation and/or damage of oligodendrocyte precursors (OPC) and late oligodendrocyte progenitors (OL) mediates periventricular white matter injury (PWMI) and its vast spectrum of cerebral injury observed among subjects, including human beings. My research focus is to better understand the mechanistic pathway p38 mitogen activated protein kinase (MAPK) on OL development and how it can be manipulated for therapeutic purposes. Specifically, I am working on determining the role of p38 mitogen activated protein kinase (MAPK) on OL development in neonatal mice reared in hypoxic conditions, a validated rodent model of PMWI.
- Michele Cox, Christopher Wendler, Ildiko Erdelyi, Amanda Beck, Scott Rivkees. 2013. Chronic Diazoxide Therapy is not Associated with Adverse Effects on Behavior. Submitted for publication
- M. M. Cox, A. M. Tucker, J. Tang, K. Talbot, D. C. Richer, L. Yeh, S. E. Arnold. 2009. Neurobehavioral Abnormalities in the Dysbindin-1 Mutant Mouse “Sandy,” on a C57BL/6J Genetic Background. Genes, Brain & Behavior 8(4): 390-397